Günümüzün önemli halk sağlığı sorunlarından biri olan obezite, alınan ve harcanan enerji arasındaki dengesizlik sonucu yağ dokusunun artmasıdır. Obezitenin kolay ve yaygın kullanılan tanı ölçütü beden kitle indeksidir (BKİ). Kilogram cinsinden ölçülen beden ağırlığının santimetre cin-sinden ölçülen boyun karesine bölünmesi ile elde edilen BKİ'nin 18,5-24,9 arasında olması normal iken; 25-29,9 arası kilolu, 30 ve üstündeki değerler ise obezite olarak kabul edilmektedir. [1] Obezitenin etyolojisinde biyolojik, psikolojik, sosyal ve çevresel birçok faktör rol almaktadır. Bu nedenle obez bireylerin yönetiminde psikolojik des-Özet Amaç: Obezite, psikososyal boyutları olan bir hastalık olarak değerlendirilmekte ve tedavisinde çok boyutlu bir terapi yaklaşımının gerekli olduğu düşünülmektedir. Birbirine yakın kavramlar olan benlik saygısı ve beden algısı obezite ile ilişkili görünmektedir. Bu çalışmada beden kitle indeksi (BKİ) ile benlik saygısı ve beden algısı arasındak ilişkinin incelenmesi amaçlanmıştır. Yöntem: Tanımlayıcı ve kesitsel tipteki çalışmanın verileri 15 Aralık 2013-5 Ocak 2014 tarihleri arasında internet üzerinden toplanmış, benlik saygısı Rosenberg Benlik Saygısı Ölçeği ve beden algısı da Beden Algısı Ölçeği ile değerlendirilmiştir. Veriler SPSS paket programı ile analiz edilmiştir. Bulgular: Çalışmaya alınan 816 kişiden 704'ü (%86,3) kadın olup yaş ortalaması 25,2±7,5 yıldı; %67,0'sinin (s=547) eğitim düzeyi üniversite ve üstüydü. Beden kitle indeksi kategorisine göre normal bireyler referans alındığında obezlerde düşük benlik saygısı bulunma oranının 1,49 (p=0,050; %95 GA=1,08-2,23) ve morbid obezlerde 3,31 kat (p=0,042; %95 GA=1,04-10,55) daha fazla olduğu; olumsuz beden algısının ise normal bireyler referans alındığında morbid obezlerde 5,48 kat (p=0,029; %95 GA=1,18-25,38) daha fazla olduğu bulundu. Sonuç: Obez bireylerde normal bireylere nazaran daha düşük benlik saygısı ve beden algısı olduğu görülmüştür.
The LupusQoL is a disease-specific health-related quality of life (HRQoL) measure for patients with lupus. We conducted this study to compare the efficiency of LupusQoL-TR (validated Turkish version of the LupusQoL questionnaire) with the 36-item Short-Form Health Survey (SF-36), a generic quality of life (QoL) scale, in Turkish patients with lupus. Both questionnaires were conducted at a single visit to the clinic. Disease activity was measured with the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). Associations between the LupusQoL-TR and SF-36 domains were examined while also examining age, disease duration, and disease activity for each questionnaire. Descriptive statistics, Spearman's correlation coefficients, and Students t test were performed to analyze the data. A total of 113 consecutive patients with lupus (F/M 108:5, mean age 40.6 ± 11.9 years, mean disease duration 8.5 ± 7.0 years) were included, and 69 % of these were active. The median SLEDAI score was 2 (0-24), the mean global LupusQoL-TR score was 60.9 ± 23.3, and the mean SF-36 score was 41.2 ± 9.0. There was a significant correlation between LupusQoL-TR and SF-36 mean scores (r = 0.83; p < 0.001). QoL assessed by LupusQoL-TR and SF-36 did not correlate with disease activity (r = -0.11; p = 0.244 and r = -0.03; p = 0.721, respectively). LupusQoL-TR and SF-36 questionnaires were beneficial instruments in evaluating HRQoL in Turkish lupus patients. However, LupusQoL-TR and SF-36 were not associated with SLEDAI scores, which suggested that QoL might be affected by other factors besides disease activity, especially in clinically inactive or mildly active patients.
Objective: To find the frequency of night eating syndrome (NES) in different obesity groups and to determine related factors.
Objectives:Celiac disease, an autoimmune disease, is related to immune mediated intolerance to gluten. Some studies suggest that Celiac Disease was 20 times more frequent in type 1 patients with diabetes. The objective of our study was to evaluate the prevalence of celiac disease in hospital based type 1 diabetic adults.Methods:Our study was carried out retrospectively in Medeniyet University Goztepe Training and Educational Hospital in Istanbul between 2012–2013. The cohort comprised 482 type 1 patients with diabetes attending the diabetes outpatient clinic. The data were analyzed by SPSS 10.5 package program. Student’s t tests is used for comparative analyses. A p-value less than 0.05 was considered statistically significant.Results:The cohort included 482 type 1 patients with diabetes. Fifty seven of them were not evaluated for Endomysium antibody positivity. Fifteen of the remaining 425 patients were positive for anti endomysial antibody (3.5%). The prevalence of biopsy proven celiac disease was 2.3% (10/425). There was no significant difference between Endomysial antibody positive and negative groups in regard of age, sex, or duration of the disease.Conclusion:This study confirms that the celiac disease is common in type 1 diabetic patients. Since a small proportion of celiac patients are symptomatic this disorder should be screened in all adult type 1 patients with diabetes by antiendomysium antibody.
AIM: To determine the frequency and the affecting factors of the psychiatric symptoms in the caregivers of elderly patients. METHODS: The population of this cross sectional study includes caregivers of 169 elderly patients receiving informal home care services. A sample was not chosen as we tried to reach the en GirișGün geçtikçe artmakta olan yaşlı nüfusta, yaşla birlikte bireyin psikolojik ve fi zyolojik yetilerinin azalması, kronik rahatsızlıkların artması gibi birçok sorun yaşanmaktadır. Bu sorunlar yaşlıyı bağımlı ve bakıma muhtaç hale getirmektedir. Ülkemizde profesyonel olarak evde bakım hizmetlerinden; bu hizmete ihtiyaç duyanların büyük çoğunluğunun yararlanamaması, bakıma muhtaç yaşlıların bakımını aile bireylerinin üstlenmesine neden olmuştur. Bu bakım hizmetini özellikle de kadınlar üstlenmektedirler 1,2 . Yaşlılara kendi yakınları tarafından bakım verilmesi, fi ziksel ve psikolojik olarak yaşlıların kendilerini daha iyi hissetmelerini sağlamasına rağmen, yapılan çalışmalar
Background: Sarcopenia and cognitive disorders are frequently observed in older individuals. This study investigated the relationship between sarcopenia and cognitive function in this population.Methods: This cross-sectional study included 201 participants aged >65 years in Istanbul between July 1, 2020 and January 31, 2021. We screened all participants using the SARC-F (strength, assistance with walking, rising from a chair, climbing stairs, and falls) questionnaire to determine the risk of sarcopenia. Handgrip strength and skeletal muscle mass of participants at risk were measured to diagnose sarcopenia. Sarcopenia severity was evaluated using a 4-m walking speed test. We evaluated the cognitive status of participants using the Standardized Mini-Mental Test (SMMT) and the Standardized Mini-Mental Test for the Untrained (SMMT-E).Results: It was found that 10.9% (n=22) of participants was risky for sarcopenia and 6.0% (n=12) and 33.3% (n=4) had definite and severe sarcopenia, respectively. Examination of the association between cognitive impairment and SARC-F showed that 8.6% (n=14) of participants with normal cognitive function were at risk of sarcopenia compared to 20.5% (n=8) of participants with cognitive impairment (p=0.045). Evaluation of the relationship between cognitive function and sarcopenia status showed that 3.7% (n=6) of participants with normal cognitive function had sarcopenia compared to 15.4% (n=6) among participants with cognitive impairment (p=0.006).Conclusion: The rate of sarcopenia was significantly higher in older individuals with cognitive than those with normal cognitive functions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.